RISING OPPORTUNITIES IN HUMAN MICROBIOME MARKET 2026 WITH THE CURRENT STATE OF THE INDUSTRY, KEY PLAYERS SUCH AS MERCK & CO., INC., ENTEROME BIOSCIENCE, YAKULT HONSHA CO., LTD., DUPONT, METABIOMICS CORPORATION, VITHERA PHARMACEUTICALS

Human microbiome plays a major role in modern healthcare, as they allow easy digestion of food, regulation of immune system, and production of vitamins such as Vitamin K, Vitamin B, and Vitamin B12 essential for blood coagulation. Human microbiomes boosts immunity, nutrition, and others.

Market Dynamics

Increasing prevalence of C. Difficile infection (CDI) is a major factor driving human microbiome market growth. In 2010, the American Society for Microbiology, study of CDI over a 13-year period in Quebec, Canada, reported an increase in incidence from 35.6 cases per 100,000 population in 1991 to 156.3 cases per 100,000 population in 2003. According to study published in Clinical Infectious Disease journal in 2015, about 25% to 33% of antibiotic-associated diarrhea and 90% of pseudomembranous enteritis are caused by CDI. Moreover, introduction of probiotic may induce change in intestinal microbiota and can stabilize microbial communities, which may prevent gut inflammation, propelling growth of the human microbiome market over the forecast period. For instance, in October 2018, BioGaia subsidiary MetaboGen introduced two new strains Faecalibacterium prausnitzii (DSM 32379) and Desulfovibrio piger (DSM 32187) for safety study. These strains are derived from human gut microbiome.

Download Free PDF Brochure of This Exclusive Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/182

Key Players

Major players operating in the global human microbiome market include, Enterome Bioscience, Yakult Honsha Co., Ltd., DuPont, Metabiomics Corporation, ViThera Pharmaceuticals, Second Genome Inc., AOBiome LLC, Seres Therapeutics, uBiome, Inc., Rebiotix, Inc., Synthetic Biologics, Inc., MicroBiome Therapeutics LLC, Vedanta BioSciences, Osel, Inc., and Merck & Co., Inc.

The global human microbiome market size was valued at US$ 46,913.4 million in 2017, and is expected to exhibit a CAGR of 17.5% over the forecast period (2018 – 2026).

Increasing prevalence of gastrointestinal disorder and cancer is expected to propel growth of the human microbiome market

Human microbiome boosts immunity, nutrition, and other uses. High incidence of C. difficile infection is expected to propel demand for antibiotics, prebiotics, and probiotics, which in turn is expected to drive the market growth. According to the Centers for Disease Control and Prevention in 2015, Clostridium difficile infection (CDI) is one of the most common healthcare-associated infections in the U.S., affecting over 500,000 people and causing about 29,000 deaths each year. According to a study published in the Clinical Infectious Disease Journal in 2015, about 25% to 33% of antibiotic-associated diarrhea and 90% of pseudomembranous enteritis are caused by CDI.

Increasing prevalence of obesity in Asia Pacific is expected to boost the market growth

Asia Pacific holds dominant position in the global human microbiome market, owing to high prevalence of obesity shows alterations in gastrointestinal microbiota. According to Asian Development Bank Institute (ADBInstitute), June 2017 estimates around 1 billion people in Asia and the Pacific were obese and around 40.9% of adults in the region were overweight in 2013, compared with 34.6% in 1990. Increasing focus on human microbiome therapy in treatment of cancer in the region is also expected to boost the market growth. According to Asian Pacific Journal of Cancer Prevention, February 2004, in year 2000, around 3 million new cancer cases, and around 2 million cancer deaths, and around 5.4 million people living with cancer in Asia Pacific region.

Detailed Segmentation:

Global Human Microbiome Market, By Product Type:
Foods
- Probiotic
- Prebiotic
- Medical Food
Diagnostic Devices/Kits
Drugs
Others

Global Human Microbiome Market, By Application:
Therapeutics
Diagnostics

Grab Best Discount on This Exclusive Research Report @ https://www.coherentmarketinsights.com/insight/request-discount/182

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.